Litigation Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
| Docket | See Plans and Pricing | Date Filed | 2016-11-29 |
| Court | District Court, D. Delaware | Date Terminated | 2020-01-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
| Jury Demand | Defendant | Referred To | |
| Parties | ALLERGAN SALES LLC | ||
| Patents | 6,660,715; 6,858,650; 7,015,018; 7,041,786; 7,157,017; 7,304,036; 7,371,727; 7,384,980; 7,476,652; 7,704,947; 7,713,930; 7,745,409; 7,771,707; 7,855,230; 7,985,772; 8,039,009; 8,039,010; 8,044,014; 8,080,526; 8,110,553; 8,338,478; 8,449,909; 8,557,291; 8,618,049; 8,679,069; 8,748,573; 8,758,813; 8,802,628; 8,822,438; 8,933,030; 8,992,486; 9,044,398; 9,108,005; 9,248,195; 9,285,372; 9,339,507; 9,358,240; 9,526,844; 9,592,200; 9,604,008; 9,708,371; 9,763,883; RE38,551; RE44,186 | ||
| Attorneys | Samuel S. Park | ||
| Firms | Devlin Law Firm | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Biologic Drugs cited in Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc.
The biologic drugs covered by the patents cited in this case are See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , See Plans and Pricing , and See Plans and Pricing .
Details for Allergan Sales, LLC v. Teva Pharmaceuticals USA, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-13 | Discovery, including ESI, with repsect to U.S. Patent No. 9,708,371 and MPI's ANDA to June 27, 2018. Signed …2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document | ||
| 2018-05-09 | 169 | Patent/Trademark Report to Commissioner | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,708,371 B2 . (Vrana, Robert…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2018-06-12 | 183 | Stipulation to EXTEND Time | Discovery, including ESI, with repsect to U.S. Patent No. 9,708,371 and MPI's ANDA to June 27, 2018 - filed …2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
| 2018-06-26 | 191 | Stipulation to EXTEND Time | Standard for Discovery with Respect to U.S. Patent No. 9,708,371 and MPI's ANDA to July 5, 2018 - filed by…2016 21 January 2020 1:16-cv-01114 830 Patent Defendant District Court, D. Delaware | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
